Valvian is focused on cancer therapies and wants to create a center of excellence in Portugal – Science

Valvian is a new Portuguese company dedicated to biotechnology, supported by national and international partners. The company created a center of excellence in biotechnology in Portugal, which aims to become the main one in Europe. A Valvian, led by entrepreneur Nuno Prego Ramos, aims to revolutionize the development of therapies for cancer and longevity, with great support from artificial intelligence.

The new company was born from an investment by Nuno Prego Ramos, after the sale of a set of innovative therapies for the treatment of cancer in solid tumors from the company CellmAbs to BioNTech. A operation guaranteed the raising of capital for the creation of Valvian and initial financing for the development of therapies in the pre-clinical phase, that is, drug candidates. Also the creation of a new technology for the discovery and development of new therapeutic targets.

The ambition of Valvian’s founder is to make the biotechnology center an international reference. To do this, it will use artificial intelligence to map and understand biological complexities yet to be explored. This aims to translate into the creation of new therapies for chronic diseases and cancers with no known cure, establishing a new standard of innovation and effectiveness.

“A Artificial intelligence is not just a tool, but a fundamental catalyst that will revolutionize the way we approach the most challenging diseases of our era”, points out Nuno Prego Ramos, expecting substantial advances in the coming years. In addition to research and development, Valvian also intends to produce and carry out clinical translation. It is also available to create synergies with all partners in Portugal.

SAPO TEK sought to find out when and where the center will start operating and what it means in terms of talent recruitment opportunities, awaiting a response at the end of this news. O company leader adds the ambition to help shape the future of medicine and “be the engine of a true revolution in science”, while putting Portugal on the map with this global center of excellence in biotechnology. Valvian also has the ambition of becoming a leader in the sector in the next two to five years, attracting talent and international investment.